Table 3.
|
Clearance |
Acquisition in non-carrying children |
Acquisition in carrying children |
||||
---|---|---|---|---|---|---|---|
Target serotype | Exposure1 | Events | Person-time2 | Events | Person-time3 | Events | Person-time4 |
9V |
Yes |
7 |
12 |
7 |
56 |
1 |
14 |
No |
3 |
3 |
6 |
300 |
1 |
83 |
|
18C |
Yes |
7 |
16 |
9 |
87 |
0 |
11 |
No |
4 |
4 |
1 |
269 |
0 |
81 |
|
3 |
Yes |
1 |
3 |
6 |
105 |
1 |
30 |
No |
8 |
11 |
4 |
251 |
0 |
68 |
|
15BC |
Yes |
1 |
4 |
1 |
77 |
0 |
19 |
No |
5 |
12 |
7 |
279 |
0 |
77 |
|
19A |
Yes |
4 |
5 |
0 |
35 |
0 |
8 |
No |
3 |
3 |
2 |
321 |
0 |
96 |
|
19F |
Yes |
2 |
3 |
1 |
28 |
1 |
8 |
No |
2 |
8 |
2 |
328 |
1 |
93 |
|
11A |
Yes |
2 |
2 |
0 |
18 |
0 |
8 |
No |
0 |
4 |
1 |
338 |
5 |
98 |
|
14 |
Yes |
0 |
0 |
0 |
12 |
0 |
5 |
No |
3 |
4 |
2 |
344 |
1 |
103 |
|
35F |
Yes |
0 |
1 |
1 |
40 |
0 |
13 |
No |
1 |
3 |
1 |
316 |
2 |
95 |
|
38 |
Yes |
0 |
0 |
0 |
24 |
0 |
13 |
No |
2 |
3 |
2 |
332 |
0 |
96 |
|
22 |
Yes |
0 |
0 |
0 |
20 |
0 |
0 |
No |
1 |
5 |
0 |
336 |
2 |
107 |
|
33 |
Yes |
0 |
0 |
0 |
0 |
0 |
0 |
No |
0 |
0 |
2 |
356 |
0 |
112 |
|
6A |
Yes |
0 |
0 |
0 |
8 |
0 |
6 |
No |
1 |
1 |
1 |
348 |
0 |
105 |
|
6B |
Yes |
0 |
0 |
0 |
12 |
0 |
7 |
No |
1 |
2 |
1 |
344 |
0 |
103 |
|
7 |
Yes |
0 |
0 |
0 |
9 |
0 |
1 |
No |
1 |
1 |
1 |
347 |
0 |
110 |
|
10 |
Yes |
0 |
0 |
0 |
4 |
0 |
2 |
No |
1 |
1 |
0 |
352 |
0 |
109 |
|
18B |
Yes |
0 |
0 |
0 |
3 |
0 |
1 |
No |
1 |
1 |
0 |
353 |
0 |
110 |
|
35B |
Yes |
0 |
0 |
0 |
0 |
0 |
0 |
No |
0 |
0 |
1 |
356 |
0 |
112 |
|
9N |
Yes |
0 |
0 |
0 |
0 |
0 |
0 |
No |
0 |
0 |
1 |
356 |
0 |
112 |
|
165 |
Yes |
0 |
0 |
0 |
7 |
0 |
4 |
No |
0 |
0 |
0 |
349 |
0 |
108 |
|
Total: | Yes |
24 |
46 |
25 |
545 |
3 |
150 |
No | 37 |
66 |
35 |
6575 |
12 |
1978 |
|
61 | 112 | 60 | 7120 | 15 | 2128 |
The crude estimates of the model parameters are (cf. Appendix): the transmission rate (per month); the community acquisition rate per serotype (in non-carrying children) (per month); the clearance rate of carriage (per month); the competition parameter . For parameter β, the denominator (85.26) is not directly readable from the data as presented in the table. Only samples from two consecutive visits were considered (85% of the scheduled pairs of consecutive visits).
1 Exposure is here defined as the presence of at least one carrier of the target serotype in the other attendees in the room.
2 Person-time here is the total time, in months, spent carrying pneumococcus overall (total row) or a specific serotype (serotype rows) stratified by the presence or absence of other carriers of the specific serotype.
3 Person-time here is the total time, in months, spent as a non-carrier, stratified by exposure to the specific serotype. For the total row, the time is a sum of serotype-specific person-times.
4 As in 2 but for children carrying pneumococcus.
5 Sampled only once in a child which was missing at the next visit.